Borrelia burgdorferi requires the alternative sigma factor RpoS for dissemination within the vector during tick-to-mammal transmission.

PLoS Pathogens
Star Dunham-EmsJ D Radolf

Abstract

While the roles of rpoS(Bb) and RpoS-dependent genes have been studied extensively within the mammal, the contribution of the RpoS regulon to the tick-phase of the Borrelia burgdorferi enzootic cycle has not been examined. Herein, we demonstrate that RpoS-dependent gene expression is prerequisite for the transmission of spirochetes by feeding nymphs. RpoS-deficient organisms are confined to the midgut lumen where they transform into an unusual morphotype (round bodies) during the later stages of the blood meal. We show that round body formation is rapidly reversible, and in vitro appears to be attributable, in part, to reduced levels of Coenzyme A disulfide reductase, which among other functions, provides NAD+ for glycolysis. Our data suggest that spirochetes default to an RpoS-independent program for round body formation upon sensing that the energetics for transmission are unfavorable.

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F C FangD G Guiney
Apr 1, 1989·Molecular & General Genetics : MGG·A Nishimura, Y Hirota
Jan 1, 1995·Methods in Molecular Biology·D S Samuels
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·T G SchwanP A Rosa
Apr 1, 1995·Trends in Genetics : TIG·W L Tung, K C Chow
Sep 1, 1993·The Journal of Infectious Diseases·R P SmithA Spielman
May 1, 1993·Journal of Clinical Microbiology·R J PollackA Spielman
Apr 13, 2000·Journal of Bacteriology·J L BonoP Rosa
Jul 14, 2000·Journal of Bacteriology·M WhiteleyE P Greenberg
Aug 23, 2000·The Journal of Clinical Investigation·U PalE Fikrig
Feb 24, 2001·Proceedings of the National Academy of Sciences of the United States of America·J OhnishiA M de Silva
Sep 5, 2002·Microbiology and Molecular Biology Reviews : MMBR·Regine Hengge-Aronis
Oct 7, 2003·Annual Review of Microbiology·Tanja M Gruber, Carol A Gross
Jan 15, 2004·The Journal of Clinical Investigation·Utpal PalErol Fikrig
Feb 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Dorothee GrimmPatricia A Rosa
Feb 26, 2004·The Journal of Experimental Medicine·Xiaofeng F YangMichael V Norgard
Jul 1, 2004·Molecular Microbiology·Ari B Molofsky, Michele S Swanson
Dec 31, 2005·Microbiology·João C SetubalDavid A Haake
Jan 4, 2008·The Journal of Infectious Diseases·Utpal PalErol Fikrig
Apr 11, 2008·Molecular Microbiology·Justin D Radolf, Melissa J Caimano
Sep 27, 2008·Journal of Neuroinflammation·Judith MiklossyPatrick L McGeer
Sep 10, 2009·Annual Review of Pathology·Candece L GladsonWei Michael Liu
Oct 13, 2009·Veterinary Parasitology·José de la FuenteAtilio J Mangold
Oct 22, 2009·Proceedings of the National Academy of Sciences of the United States of America·Øystein BrorsonLynn Margulis
Nov 6, 2009·Molecular Microbiology·Zhiming OuyangMichael V Norgard

❮ Previous
Next ❯

Citations

Jun 26, 2012·The Journal of Clinical Investigation·Linda K BockenstedtAlexia A Belperron
Dec 21, 2013·PloS One·Linxu ChenFang Ting Liang
Jul 24, 2013·Trends in Microbiology·Jenifer CoburnGeorge Chaconas
Mar 5, 2013·Biochemical and Biophysical Research Communications·Linda ArchambaultPaula Schlax
Nov 1, 2015·Current Opinion in Microbiology·Md A MotalebR Mark Wooten
Nov 26, 2015·Clinics in Laboratory Medicine·Mary Petzke, Ira Schwartz
Jan 8, 2015·Microbiology·Leena MeriläinenLeona Gilbert
May 14, 2014·Frontiers in Cellular and Infection Microbiology·Elizabeth A NovakMd A Motaleb
Feb 7, 2014·Clinical and Vaccine Immunology : CVI·Kevin S BrandtRobert D Gilmore
Jun 22, 2016·Infection and Immunity·Zhiming OuyangMichael V Norgard
Jan 24, 2014·Infection and Immunity·Zhiming OuyangMichael V Norgard
Nov 20, 2019·Molecular Microbiology·Dan DrecktrahD Scott Samuels
Oct 31, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Catherine Menten-DedoyartBernard Couvreur
May 6, 2016·Cellular Microbiology·Melissa J CaimanoD Scott Samuels
Jul 22, 2018·Frontiers in Cellular and Infection Microbiology·Dan DrecktrahD Scott Samuels
May 18, 2019·Parasites & Vectors·Natalie RudenkoMarie Vancova
Jan 1, 2020·Pathogens·Vladimir V BammMelanie K B Wills
Sep 16, 2020·Infection and Immunity·Danielle E GrahamJon S Blevins
Nov 17, 2020·Frontiers in Medicine·Qiang LiuYongliang Lou

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
light scattering
transmission electron microscopy
confocal microscopy

Software Mentioned

QuickTime Player
StreamPix
iCycler
Image Capture Engine
QCapture
Prism
Adobe Photoshop

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.